JPRN-jRCT2080221475未知3 期
ong-term study of SMP-862 in patients with paediatric type 2 diabetes mellitus
适应症
试验速览
- 阶段
- 3 期
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 6age old 至 <= 17age old（—）
- 性别
- All
入选标准
- •Patients who have undergone diet and exercise therapy prior to initiation of treatment
- •- HbA1c immediately prior to enrolment is >= 7.0% etc.
排除标准
- •- Patients receiving insulin therapy
- •- Patients with moderate or severe renal dysfunction
- •- Patients with severe hepatic dysfunction etc.
研究者
相似试验
未知
3 期
ong-term Study of DSP-8153 in patients with essential hypertensioHypertensionJPRN-jRCT2080221238Dainippon Sumitomo Pharma Co., Ltd.
未知
2 期
A phase II confirmatory study of SMP-862 therapy in patients with type 2 diabetes mellitus who are concomitantly taking sulfonylureasJPRN-jRCT2080220089Dainippon Sumitomo Pharma Co., Ltd.
已完成
2 期
A phase 2 study of S-812217 in patients with major depressive disorderJPRN-jRCT2080225180SHIONOGI & CO., LTD.240
未知
2 期
A phase II confirmatory study of SMP-862 monotherapy in patients with type 2 diabetes mellitusJPRN-jRCT2080220088Dainippon Sumitomo Pharma Co., Ltd.
招募中
3 期
A phase 3 study of S-812217 in patients with major depressive disorderdepressionJPRN-jRCT2031210577agata Tsutae400